CMTM5 Polyclonal Antibody

Rabbit Anti-CMTM5 Polyclonal Antibody

Product Specifications

Background

CMTM5 encodes a member of the chemokine-like factor superfamily. This family of genes encodes multi-pass membrane proteins that are similar to both the chemokine and the transmembrane 4 superfamilies of signaling molecules. The CKLF like MARVEL transmembrane domain containing 5 may exhibit tumor suppressor activity. Alternative splicing results in multiple transcript variants.

CAS Number

9007-83-4

Product Name Alternative

CMTM5; CKLFSF5; CKLF-like MARVEL transmembrane domain-containing protein 5; Chemokine-like factor superfamily member 5

Gene ID

116173

Accession Number

Q96DZ9

Reactivity

Human, Mouse

Immunogen

Synthesized peptide derived from the N-terminal region of human CMTM5

Clonality

Polyclonal

Tag

CKLF-like MARVEL transmembrane domain-containing protein 5

Applications

WB, IHC, IF, ELISA

Purification Method

The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

Concentration

1 mg/ml

Molecular Weight

25kD

Precautions

The product listed herein is for research use only and is not intended for use in human or clinical diagnosis. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license. We cannot be responsible for patent infringements or other violations that may occur with the use of this product.

Shipping Conditions

Gel pack with blue ice.

Storage Conditions

Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.

Notes

CMTM5 Polyclonal Antibody detects endogenous levels of CMTM5 protein.

Observed Molecular Weight

Formulation

Liquid solution

Buffer pH

Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

Applications Notes

Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB 1:500-1:2000; IHC: 1:100-1:300; ELISA 1:20000; IF 1:50-200